MGC Diagnostics (MGCD) Reports Q1 EPS of $0.00
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
MGC Diagnostics Corporation Reports Fiscal 2016 First Quarter Results
March 8, 2016 4:01 PM ESTSAINT PAUL, Minn., March 8, 2016 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the first quarter ended January 31, 2016.
First Quarter Fiscal 2016 Highlights:
First quarter 2016 revenue increased by 3.4% to $9.3 million, compared to $8.9 million in the prior year period. Medical Graphics' revenue increased 4.9% to $8.1 million, compared to $7.7 million in the first quarter of fiscal 2015. Medisoft's revenue fell 6.0% to $1.15 million from $1.23 million in the first quarter of fiscal 2015. Service revenue increased by 3.5% to $1.71 million in the fiscal first quarter... More